L’Oreal to Sell $3.1 Billion Stake in Sanofi Back to Pharma Group
The deal will diversify the French beauty giant’s funding sources at a time when the industry is undergoing a slowdown.
Hosted on MSN3d
Sanofi kicks off share buyback plan with $3bn L’Oréal stake purchase
L'Oréal is selling nearly 30 million shares in Sanofi, decreasing its stake in the drugmaker from 9.4% to 7.2%.
GlobalData on MSN6d
Sanofi reports Q4 2024 increase in net income to $916m
Sanofi has announced an increase in net income from continuing operations for the fourth quarter (Q4) of 2024, reaching €880m ...
Sanofi’s Promising Future: Buy Rating Backed by Strategic Moves and Strong Pipeline
Sanofi (SNYNF – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst David Risinger from ...
GlobalData on MSN3d
Sanofi’s Sarclisa combo approved in China for multiple myeloma
Sanofi has received China’s National Medical Products Administration (NMPA) approval for the use of Sarclisa (isatuximab), ...
Sanofi Expected to Report Lower Sales, Profit; Size of Buyback in Focus -- Earnings Preview
BUSINESS OPERATING PROFIT FORECAST: Business operating profit--one of the company's preferred metrics, which strips out exceptional items--is forecast at 2.08 billion euros, according to the Vara ...
Time To Be Bullish On Sanofi Ahead Of Its Earnings
Dupixent continues leading among Sanofi’s portfolio, and it’s poised for up to $20 billion in peak sales. Read my SNY ...
American Association of Individual Investors6d
Which Is a Better Investment, Sanofi or Zoetis Inc. Stock?
Learn more about whether Sanofi or Zoetis Inc. is a better investment based on AAII's A+ Investor grades, which compare both ...
Cosmetics Business3d
L’Oréal sells €3 billion of Sanofi stock back to pharmaceutical group
The beauty giant said the transaction – selling approximately 29.6 million of its Sanofi shares for €101.5 per share – will ...
Sanofi: Positioned for Strong Growth with Conservative Guidance and Strategic Initiatives
Analyst Graham Parry of Bank of America Securities reiterated a Buy rating on Sanofi (SNYNF – Research Report), boosting the price target to ...
Bredin, Cleary Guide Sanofi’s €3B Share Buyback From L’Oreal
In other deals, Linklaters, Willkie and Latham are advising as PAI Partners negotiates to buy a stake in Alvest, a France-based provider of ground support equipment for airports, in a deal worth an ...
Agreement Between L’Oréal and Sanofi for the Repurchase by Sanofi of 2.3% of Its Own Shares Held by L’Oréal
AGREEMENT BETWEEN L’ORÉAL AND SANOFI FOR THE REPURCHASEBY SANOFI OF 2.3% OF ITS OWN SHARES HELD BY L’ORÉAL Clichy, February 3, 2025 – L’Oréal announces today that it has agreed to sell approximately ...